United States · FDA National Drug Code directory
Proctozone GMax
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 57237-339_8e27aa33-f09a-42d8-8cfe-efe6ca44f9b4
- Product NDC
- 57237-339
- Form
- SUPPOSITORY
- Composition / generic term
- Glycerin
- Labeler
- Rising Pharma Holdings, Inc.
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start / end (source format)
- 20250731
- Source listing expiry
- 20271231
Source-listed ingredients
- GLYCERIN — 2 g/1
These values do not establish equivalence or a dose recommendation.
Packages
- 2 BLISTER PACK in 1 CARTON (57237-339-21) / 6 SUPPOSITORY in 1 BLISTER PACK (57237-339-16) · 57237-339-21
- 5 BLISTER PACK in 1 CARTON (57237-339-52) / 5 SUPPOSITORY in 1 BLISTER PACK (57237-339-51) · 57237-339-52
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →